-
EP2968210
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2968210
| EP2968210 - PHENYL CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING PEDIATRIC EPILESY [Right-click to bookmark this link] | |||
| Former [2016/03] | PHENYL CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING PEDIATRIC EPILESY AND EPILESY-RELATED SYNDROMES | ||
| [2024/14] | Status | The patent has been granted Status updated on 08.08.2024 Database last updated on 31.08.2024 | |
| Former | Grant of patent is intended Status updated on 01.04.2024 | ||
| Former | Examination is in progress Status updated on 22.06.2018 | Most recent event Tooltip | 08.08.2024 | (Expected) grant | published on 11.09.2024 [2024/37] | Applicant(s) | For all designated states Bio-Pharm Solutions Co., Ltd. Fl. 6, C dong 145, Gwanggyo-ro Yeongtong-gu Suwon-si, Gyeonggi-do 443-270 / KR | [2024/37] |
| Former [2016/03] | For all designated states Bio-Pharm Solutions Co., Ltd. C-dong 145 Gwanggyo-ro Yeongtong-gu Suwon-si, Gyeonggi-do 443-270 / KR | Inventor(s) | 01 /
CHOI, Yong Moon Fl. 6, C dong, 145, Gwanggyo-ro Yeongtong-gu, Suwon-si Gyeonggi-do, 443-270 / KR | [2016/03] | Representative(s) | Stolmár & Partner Patentanwälte PartG mbB Blumenstraße 17 80331 München / DE | [2016/03] | Application number, filing date | 14762362.3 | 07.03.2014 | [2016/03] | WO2014KR01903 | Priority number, date | US201361776926P | 12.03.2013 Original published format: US 201361776926 P | [2016/03] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2014142477 | Date: | 18.09.2014 | Language: | EN | [2014/38] | Type: | A1 Application with search report | No.: | EP2968210 | Date: | 20.01.2016 | Language: | EN | The application published by WIPO in one of the EPO official languages on 18.09.2014 takes the place of the publication of the European patent application. | [2016/03] | Type: | B1 Patent specification | No.: | EP2968210 | Date: | 11.09.2024 | Language: | EN | [2024/37] | Search report(s) | International search report - published on: | KR | 18.09.2014 | (Supplementary) European search report - dispatched on: | EP | 25.11.2016 | Classification | IPC: | A61K31/27, A61K31/325, A61P25/08 | [2024/14] | CPC: |
A61K31/325 (EP,US);
A61K31/166 (KR);
A61K31/03 (EP,US);
A61K31/045 (KR);
A61K31/047 (KR);
A61K31/055 (KR);
A61K31/135 (KR);
A61K31/27 (EP,KR,US);
A61P21/00 (EP);
A61P21/02 (EP);
A61P25/00 (EP);
A61P25/08 (EP);
A61P25/10 (EP);
A61P25/12 (EP);
A61P25/16 (EP);
C07C271/12 (KR,US);
C07C271/24 (KR,US);
C07C2601/02 (EP,US);
|
| Former IPC [2016/03] | A61K31/055, A61K31/047, A61K31/045, A61K31/135, A61P25/00 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2016/03] | Extension states | BA | Not yet paid | ME | Not yet paid | Title | German: | PHENYLCARBAMATVERBINDUNGEN ZUR VERWENDUNG IN DER VORBEUGUNG ODER BEHANDLUNG PÄDIATRISCHER EPILEPSIE | [2024/14] | English: | PHENYL CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING PEDIATRIC EPILESY | [2024/14] | French: | COMPOSÉS PHÉNYL CARMABATE DESTINÉS À L'UTILISATION DANS LA PRÉVENTION OU LE TRAITEMENT DE L'ÉPILEPSIE PÉDIATRIQUE | [2024/14] |
| Former [2016/03] | PHENYLCARBAMATVERBINDUNGEN ZUR VERWENDUNG IN DER VORBEUGUNG ODER BEHANDLUNG PÄDIATRISCHER EPILEPSIE UND EPILEPSIE-VERMITTELTER SYNDROME | ||
| Former [2016/03] | PHENYL CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING PEDIATRIC EPILESY AND EPILESY-RELATED SYNDROMES | ||
| Former [2016/03] | COMPOSÉS PHÉNYL CARMABATE DESTINÉS À L'UTILISATION DANS LA PRÉVENTION OU LE TRAITEMENT DE L'ÉPILEPSIE PÉDIATRIQUE OU DES SYNDROMES APPARENTÉS À L'ÉPILEPSIE | Entry into regional phase | 21.09.2015 | National basic fee paid | 21.09.2015 | Search fee paid | 21.09.2015 | Designation fee(s) paid | 21.09.2015 | Examination fee paid | Examination procedure | 21.09.2015 | Examination requested [2016/03] | 19.06.2017 | Amendment by applicant (claims and/or description) | 26.06.2018 | Despatch of a communication from the examining division (Time limit: M04) | 21.09.2018 | Reply to a communication from the examining division | 30.09.2019 | Despatch of a communication from the examining division (Time limit: M06) | 26.05.2020 | Reply to a communication from the examining division | 25.11.2021 | Despatch of a communication from the examining division (Time limit: M04) | 25.03.2022 | Reply to a communication from the examining division | 02.04.2024 | Communication of intention to grant the patent | 02.08.2024 | Fee for grant paid | 02.08.2024 | Fee for publishing/printing paid | 02.08.2024 | Receipt of the translation of the claim(s) | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 26.06.2018 | Fees paid | Renewal fee | 31.03.2016 | Renewal fee patent year 03 | 31.03.2017 | Renewal fee patent year 04 | 26.03.2018 | Renewal fee patent year 05 | 01.04.2019 | Renewal fee patent year 06 | 31.03.2020 | Renewal fee patent year 07 | 31.03.2021 | Renewal fee patent year 08 | 31.03.2022 | Renewal fee patent year 09 | 30.03.2023 | Renewal fee patent year 10 | 25.03.2024 | Renewal fee patent year 11 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [I]US3313692 (BOSSINGER CHARLES D, et al); | [I]US3509162 (BESENDORF HEDWIG, et al); | [I]KR100197901B (SK CORP [KR]); | [I]WO02067925 (ORTHO MCNEIL PHARM INC [US]); | [I]WO02067923 (ORTHO MCNEIL PHARM INC [US]); | [I]WO2006033947 (JANSSEN PHARMACEUTICA NV [BE], et al); | [I]WO2007008551 (JANSSEN PHARMACEUTICA NV [BE], et al); | [I]WO2008048802 (JANSSEN PHARMACEUTICA NV [BE], et al); | [I]US2013005801 (CHOI YONG MOON [US]); | [IP]WO2013100571 (BIO PHARM SOLUTIONS CO LTD [KR]); | [IP]WO2013100570 (BIO PHARM SOLUTIONS CO LTD [KR]); | International search | [X]US2001034365 (CHOI YONG MOON [US], et al); | [A]US2008260813 (THAKUR MADHAV S [US], et al); | [A]US2010210590 (WATTERSON MARTIN D [US], et al); | [A]WO2012002773 (BIO PHARM SOLUTIONS CO LTD [KR], et al); | [A]US2012184762 (CHOI YONG MOON [US]) | by applicant | US2013005801 | - The Treatment of Epilepsy, Principles & Practice |